New survey shows nearly 70% of older adults in Singapore underestimate their risk of shingles; only 1 in 4 plans to consult their doctor on prevention
- Written by Reporters
- A survey by Ipsos, sponsored by GSK, found that while 63% of adults aged 50 years or over in Singapore were aware of shingles, only 29% recognised that 1 in 3 may develop the disease in their lifetime.
- Less than half of respondents (44%) understood that shingles can increase the risk of stroke or heart attack; fewer (36%) knew that the risk for shingles further increases amongst those with underlying chronic health conditions such as chronic obstructive pulmonary disease (COPD), cardiovascular disease, or diabetes.
- Only 1 in 4 intended to discuss shingles prevention with their doctor within the next three months.
- Survey findings reinforce need for deeper understanding of shingles and to encourage older adults to consult their doctors on shingles prevention.

A shingles awareness community ambassador (left) demonstrates a simulation of long-term pain or postherpetic neuralgia (PHN), a potential complication of shingles.11 Photo: GSK.
Ms Claire, who is in her forties, shared in a conversation with GSK, "When my father had shingles for the second time around, he was in his 60's.13 And he came out one day, saying 'Look, take a look at this,' and there were rashes on his forehead and a little bit on his torso.13 He said that there was stinging pain,11 and I could feel that he was undergoing this pain because he did not wipe his face and wash. He would wake up a few times at night because of the pain on his forehead and body." 
Claire is a caregiver to her father, Christopher, who was diagnosed with shingles twice. Photo: GSK.
"While we see that overall awareness continues to improve, we need to further strengthen the understanding of our communities on the increased risk of shingles amongst adults aged 50 years or over — and it can be prevented. Go speak with your doctor," said Dr Asok. References 1 Ipsos. Shingles Awareness Tracking Survey Wave 4: Consumers Singapore. August 2025. Version 1. Study reference: 25-023546-01. Client Use Only. Strictly Confidential. 2 Kim, M. C., Yun, S. C., Lee, H. B., Lee, P. H., Lee, S. W., Choi, S. H., Kim, Y. S., Woo, J. H., Kim, S. H., & Kwon, S. U. (2017). Herpes Zoster Increases the Risk of Stroke and Myocardial Infarction. Journal of the American College of Cardiology, 70(2), 295–296. https://doi.org/10.1016/j.jacc.2017.05.0153 Steinmann M, Lampe D, Grosser J, Schmidt J, Hohoff ML, Fischer A, Greiner W. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns. Infection. 2024 Jun;52(3):1009-1026. doi: 10.1007/s15010-023-02156-y. Epub 2024 Jan 18. PMID: 38236326; PMCID: PMC11142967. 4 Chan, A., Malhotra, R., Visaria, A., Sung, P., Siok Seng, B. J., Ching, & Tan, Y. W. (2020). Transitions in health, employment, social engagement and intergenerational Transfers in Singapore Study (THE SIGNS Study) – II: Cross-Sectional and Longitudinal analyses of Key aspects of Successful Ageing. Centre for Ageing Research and Education, Duke-NUS Medical School. https://www.duke-nus.edu.sg/docs/librariesprovider3/publications-docs/the-signs-study---ii-report-(revised).pdf?sfvrsn=b391ced0_05 Harpaz R et al. MMWR Recomm Rep 2008;57:1-30; quiz CE2-4. 6 Centers for Disease Control and Prevention. Herpes Zoster (Shingles). Available at: https://www.cdc.gov/shingles/hcp/clinical-overview.html. Accessed May 2022. 7 Johnson, R.W., et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Therapeutic advances in vaccines. 2015;3(4):109-20. 8 Mueller, N.H., et al. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurologic clinics. 2008;26(3):675-97. 9 Centers for Disease Control and Prevention (US). Morbidity and Mortality Weekly Report. Prevention of Herpes Zoster. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5705a1.htm. Accessed May 2022. 10 Fatha N, et al. Int J Infect Dis. 2014;22:73-77. 11 World Health Organization (WHO). Shingles (Herpes Zoster): Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/shingles-(herpes-zoster)Accessed on 13 October 2025. 12 CDC;2024;1-3;Shingles Facts and Stats. 13 CDC; 2024;1-4; Shingles Symptoms and Complications. The issuer is solely responsible for the content of this announcement.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com/en-gb/company/.
About the Shingles Awareness Tracking Survey
The Shingles Awareness Tracking Survey was an online survey of 200 adults aged 50 years or over, conducted between 14 July to 31 July 2025 by Ipsos, on behalf of GSK. The purpose of this survey was to assess consumer awareness and perceptions of Shingles in Singapore.
Source https://www.media-outreach.com/news/singapore/2025/10/22/420877/

